Investor Alert: Argentina Loaded With "White Gold" Opportunity
Experts expect the global lithium market to grow by 500% due to the explosion of electric vehicles and green energy. And one small-cap company just snagged a large lithium deposit in a renowned South American location.
Read about this once-in-a-lifetime opportunity

MDC Insider Trading (Medlab Clinical)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$36,999.93
Insider Selling (Last 12 Months): A$0.00

Medlab Clinical Insider Trading History Chart

This chart shows the insider buying and selling history at Medlab Clinical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Medlab Clinical Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for MDC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Bargain in Today's Market (SHOCKING)
This "World's Most Admired" company's stock would be a bargain at $50...Today it's just $2! Plus... a key May 12 announcement could send it ROCKETING skyward...

Click Here Now (Before It's Too Late!)
>>>

Medlab Clinical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/4/2022Sean HallInsiderBuy109,890A$0.09A$9,999.99
3/30/2022Sean HallInsiderBuy95,744A$0.09A$8,999.94
11/4/2021Sean HallInsiderBuy100,000A$0.18A$18,000.00
10/18/2021Cheryl MaleyInsiderIssued1,500,000A$0.16A$240,000.00
11/12/2020Drew TownsendInsiderIssued2,000,000A$0.19A$370,000.00
4/14/2020Michael HallInsiderSell68,707A$0.27A$18,619.60
7/1/2019Michael HallInsiderExercise850,000A$0.30A$255,000.00
5/23/2019Michael HallInsiderSell30,000A$0.41A$12,330.00
See Full Table
How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.

We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.

SEC Filings (Institutional Ownership Changes) for Medlab Clinical (ASX:MDC)

Medlab Clinical logo
Medlab Clinical Limited, a biotechnology company, researches, develops, and commercializes pharmaceutical and nutraceutical products in Australia. Its lead drug candidate includes NanaBis, an oro-buccal administered equimolar tetrahydrocannabinol (THC) and cannabidiol (CBD) formulation as monotherapy, which is in phase 3 multi-centre, quadruple-blind, randomized- withdrawal active, and placebo-controlled clinical study for the management of opioid-requiring-bone-pain due to metastatic cancer. The company also develops NanoCelle, a patented sub-micron drug delivery platform that enhances drug solubility issues and enables faster absorption and metabolism of active ingredients. In addition, it offers vitamins and supplements; and virtual clinic services. Medlab Clinical Limited was founded in 2012 and is headquartered in Botany, Australia.
Read More on Medlab Clinical

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

36,677 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Medlab Clinical?

Medlab Clinical's top insider investors include:
  1. Cheryl Maley (Insider)
  2. Drew Townsend (Insider)
  3. Sean Hall (Insider)
Learn More about top insider investors at Medlab Clinical.
How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.

We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.